A risk score based on baseline risk factors for predicting mortality in COVID-19 patients.


Journal

Current medical research and opinion
ISSN: 1473-4877
Titre abrégé: Curr Med Res Opin
Pays: England
ID NLM: 0351014

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 18 3 2021
medline: 22 6 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

To develop a sensitive and clinically applicable risk assessment tool identifying coronavirus disease 2019 (COVID-19) patients with a high risk of mortality at hospital admission. This model would assist frontline clinicians in optimizing medical treatment with limited resources. 6415 patients from seven hospitals in Wuhan city were assigned to the training and testing cohorts. A total of 6351 patients from another three hospitals in Wuhan, 2169 patients from outside of Wuhan, and 553 patients from Milan, Italy were assigned to three independent validation cohorts. A total of 64 candidate clinical variables at hospital admission were analyzed by random forest and least absolute shrinkage and selection operator (LASSO) analyses. Eight factors, namely, The OURMAPCN score is a risk assessment tool to determine the mortality rate in COVID-19 patients based on a limited number of baseline parameters. This tool can assist physicians in optimizing the clinical management of COVID-19 patients with limited hospital resources.

Sections du résumé

BACKGROUND
To develop a sensitive and clinically applicable risk assessment tool identifying coronavirus disease 2019 (COVID-19) patients with a high risk of mortality at hospital admission. This model would assist frontline clinicians in optimizing medical treatment with limited resources.
METHODS
6415 patients from seven hospitals in Wuhan city were assigned to the training and testing cohorts. A total of 6351 patients from another three hospitals in Wuhan, 2169 patients from outside of Wuhan, and 553 patients from Milan, Italy were assigned to three independent validation cohorts. A total of 64 candidate clinical variables at hospital admission were analyzed by random forest and least absolute shrinkage and selection operator (LASSO) analyses.
RESULTS
Eight factors, namely,
CONCLUSIONS
The OURMAPCN score is a risk assessment tool to determine the mortality rate in COVID-19 patients based on a limited number of baseline parameters. This tool can assist physicians in optimizing the clinical management of COVID-19 patients with limited hospital resources.

Identifiants

pubmed: 33729889
doi: 10.1080/03007995.2021.1904862
pmc: PMC8054492
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

917-927

Auteurs

Ze Chen (Z)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Jing Chen (J)

Institute of Model Animal, Wuhan University, Wuhan, China.
School of Mathematics and Physics, Wuhan Institute of Technology, Wuhan, China.

Jianghua Zhou (J)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Fang Lei (F)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Feng Zhou (F)

Institute of Model Animal, Wuhan University, Wuhan, China.
Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.

Juan-Juan Qin (JJ)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Xiao-Jing Zhang (XJ)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Lihua Zhu (L)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Ye-Mao Liu (YM)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Haitao Wang (H)

Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

Ming-Ming Chen (MM)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Yan-Ci Zhao (YC)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Jing Xie (J)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.

Lijun Shen (L)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Xiaohui Song (X)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Xingyuan Zhang (X)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Chengzhang Yang (C)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Weifang Liu (W)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Xiao Zhang (X)

Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.

Deliang Guo (D)

Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

Youqin Yan (Y)

Infections Department, Wuhan Seventh Hospital, Wuhan, China.

Mingyu Liu (M)

The Ninth Hospital of Wuhan City, Wuhan, China.

Weiming Mao (W)

Department of General Surgery, Huanggang Central Hospital, Huanggang, China.

Liming Liu (L)

Department of General Surgery, Ezhou Central Hospital, Ezhou, China.

Ping Ye (P)

Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Bing Xiao (B)

Department of Stomatology, Xiantao First People's Hospital, Xiantao, China.

Pengcheng Luo (P)

Department of Urology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, China.

Zixiong Zhang (Z)

The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.

Zhigang Lu (Z)

Department of Neurology, The First People's Hospital of Jingmen affiliated to Hubei Minzu University, Jingmen, China.

Junhai Wang (J)

Department of Orthopedics, The First People's Hospital of Jingmen affiliated to Hubei Minzu University, Jingmen, China.

Haofeng Lu (H)

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Changjiang University, Jingzhou, China.

Xigang Xia (X)

Department of Hepatobiliary Surgery, Jingzhou Central Hospital, Jingzhou, China.

Daihong Wang (D)

Department of Hepatobiliary and Pancreatic Surgery, Xianning Central Hospital, Hubei Province, Xianning, China.

Xiaofeng Liao (X)

Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.

Gang Peng (G)

Department of Hepatobiliary and Pancreatic Surgery, Suizhou Central Hospital Affiliated to Hubei Medical College, Suizhou, China.

Liang Liang (L)

Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital and Institute of Cardiovascular Diseases, China Three Gorges University, Yichang China.

Jun Yang (J)

Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital and Institute of Cardiovascular Diseases, China Three Gorges University, Yichang China.

Guohua Chen (G)

Department of Neurology, Wuhan First Hospital/Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.

Elena Azzolini (E)

Humanitas Clinical and Research Hospital IRCCS, Rozzano-Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.

Alessio Aghemo (A)

Humanitas Clinical and Research Hospital IRCCS, Rozzano-Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.

Michele Ciccarelli (M)

Humanitas Clinical and Research Hospital IRCCS, Rozzano-Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.

Gianluigi Condorelli (G)

Humanitas Clinical and Research Hospital IRCCS, Rozzano-Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.

Giulio G Stefanini (GG)

Humanitas Clinical and Research Hospital IRCCS, Rozzano-Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy.

Xiang Wei (X)

Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Bing-Hong Zhang (BH)

Departments of Neonatology, Renmin Hospital of Wuhan University, Wuhan, China.

Xiaodong Huang (X)

Department of Gastroenterology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, China.

Jiahong Xia (J)

Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Yufeng Yuan (Y)

Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

Zhi-Gang She (ZG)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.

Jiao Guo (J)

Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine and Key Laboratory of Glucolipid Metabolic Disorder, Guangdong TCM Key Laboratory for Metabolic Diseases, Ministry of Education of China and Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.

Yibin Wang (Y)

Departments of Anesthesiology, Physiology and Medicine, Cardiovascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Peng Zhang (P)

Institute of Model Animal, Wuhan University, Wuhan, China.
Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.

Hongliang Li (H)

Department of Cardiology, Renmin Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China.
Institute of Model Animal, Wuhan University, Wuhan, China.
Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH